BAYN BAYN
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
News
1 year ago prnewswire.com
RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum
Guy Goldberg, RedHill's Chief Business Officer, presents today a business update at the European Life Sciences CEO Forum The update covers: The recent out-licensing of RHB-102 [1] to Hyloris…
1 year ago prnewswire.com
RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant prostate cancer…
6 years ago thelincolnianonline.com
JPMorgan Chase & Co. Analysts Give Bayer (FRA:BAYN) a €77.00 Price Target
Bayer (FRA:BAYN) received a €77.00 ($86.52) target price from research analysts at JPMorgan Chase & Co. in a research note issued on Wednesday, Borsen Zeitung reports. The brokerage presently has a…
6 years ago thelincolnianonline.com
Bayer (FRA:BAYN) Given a €90.00 Price Target at Sanford C. Bernstein
Bayer (FRA:BAYN) has been given a €90.00 ($101.12) target price by equities researchers at Sanford C. Bernstein in a research report issued to clients and investors on Wednesday, Borsen Zeitung…
6 years ago thelincolnianonline.com
Bayer (FRA:BAYN) PT Set at €105.00 by Baader Bank
Baader Bank set a €105.00 ($117.98) price target on Bayer (FRA:BAYN) in a research report report published on Monday, Borsen Zeitung reports. The firm currently has a buy rating on the healthcare…